Clinical Trial Update: Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining preoperative chemoradiotherapy with cetuximab in rectal cancer, sponsored by the National Cancer Center, Korea, with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Rectal Neoplasms, Neoadjuvant Treatment | Phase 2 | Status: UNKNOWN